What is AskGene Pharma?
Founded in 2012 in Los Angeles, California, AskGene Pharma is dedicated to the discovery and development of next-generation cytokine therapeutics. The company has pioneered the cutting-edge SmartKine® cytokine prodrug platform, which significantly enhances the developability of cytokines for oncology and inflammation indications. AskGene is actively advancing multiple projects through clinical and preclinical development, positioning itself as a key player in the biopharmaceutical innovation landscape.
How much funding has AskGene Pharma raised?
AskGene Pharma has raised a total of $20.4M across 2 funding rounds:
Debt
$350K
Series A
$20M
Debt (2020): $350K with participation from PPP
Series A (2022): $20M led by TF Capital and Qiming Venture Partners
Key Investors in AskGene Pharma
TF Capital
TF Capital is a leading investor focused on partnering with early-stage innovators in the biotech sector, providing capital and strategic expertise. They have a strong track record of supporting biotech companies through financing, IPOs, and licensing deals.
Qiming Venture Partners
启明创投 is a prominent venture capital firm investing in technology, healthcare, and AI, aiming to support entrepreneurs with industry resources and strategic guidance. They have a notable track record of backing successful startups.
PPP
Public-Private Partnership
What's next for AskGene Pharma?
With a major strategic investment and substantial enterprise-level backing, AskGene Pharma is poised for accelerated growth and clinical advancement. The company's focus on its proprietary SmartKine® platform suggests a strategic direction towards optimizing cytokine therapies for challenging indications like oncology and inflammation. Future developments will likely involve progressing existing pipeline candidates through rigorous clinical trials and potentially expanding the platform's application to other therapeutic areas. This infusion of capital will be critical for scaling operations, expanding research and development efforts, and navigating the complex regulatory pathways inherent in drug development.
See full AskGene Pharma company page
